Biotechnology
Company Overview of Amarantus Bioscience Holdings, Inc
Company Overview
675 Almanor Avenue
Sunnyvale, CA 94085
United States
Founded in 2008
3 Employees
Key Executives for Amarantus Bioscience Holdings, Inc
Amarantus Bioscience Holdings, Inc Key Developments
Amarantus Bioscience Holdings, Inc.’s common stock will be deleted from OTC Bulletin Board (OTCBB) effective April 26, 2013 for failure to comply with rule NASD 6530.
On April 15, 2013, Amarantus Bioscience Holdings Inc. appointed Russell Miller as Director of Investor Relations. Mr. Miller previously served as Director of Investor Relations for US Data Works and for Force Protection Inc.
Amarantus BioScience, Inc. intends to make acquisitions. The Company intends to acquire clinical-stage drug candidate to complement Mesencephalic Astrocyte Neurotrophic Factor (MANF) within its Amarantus Therapeutics subsidiary. Gerald E. Commissiong, President and Chief Executive Officer of Amarantus BioScience said: "While our near-term development objectives remain the same, the new structure will allow us to allocate capital more efficiently, and form management teams specific to each business or product line. We will also be able to create new business units to leverage other assets we already own, such as our PhenoGuard Protein Discovery platform, or that we may acquire. Additionally, we have decided not to spinoff Amarantus Diagnostics at this time, and will re-evaluate the potential spinoff of various business units as the situation with each entity unfolds."
Similar Private Companies By Industry
| Company Name | Region |
| Assurance Biosciences, Inc. | United States |
| Nanocopoeia, Inc. | United States |
| Princeton BioMolecular Research Inc. | United States |
| Metacine, Inc. | United States |
| Millennium Biotherapeutics Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target |
|
Private Placement
June 7, 2013 |
-- |
|
Merger/Acquisition
December 20, 2012 |
Memory Dx LLC, Worldwide License to Develop, Manufacture, Market, Sell and Import Medical Devices |
|
Private Placement
November 14, 2012 |
-- |
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Illinois | Miller AgPosted: Jun 14
- Tarrytown, NY | Bridgeview ITPosted: Jun 16
- New Jersey | Marina Sirras & AssociatesPosted: Jun 14
Sponsored Financial Commentaries
Sponsored Links
To contact Amarantus Bioscience Holdings, Inc, please visit www.amarantus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
